Sibani Chakraborty

Sibani Chakraborty

Auto-generated profile, based on publicly available information

Sibani Chakraborty

West Bengal State University

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2018 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
ACAnkur Chaudhuri
Ankur Chaudhuri
SBSampa Biswas
Sampa Biswas
SCSibani Chakraborty
Sibani Chakraborty
Meprins are a group of zinc metalloproteases of the astacin family which play a pivotal role in several physiological and pathologocal diseases. The inhibition of the meprins by various inhibitors, macromolecular and small molecules, is crucial in the control of several diseases. Human cystatinC, an amyloidogenic protein, is reported to be an endogenous inhibitor of meprin-α. In this computational study, we elucidate a rational model for meprinα–cystatinC complex using protein–protein docking. The complex model as well as the unbound form was evaluated by molecular dynamics simulation. A simulation study revealed higher stability of the complex owing to the presence of several interactions. Virtual alanine mutagenesis helps in identifying the hotspots on both proteins. Based on the frequency of occurrence of hotspot amino acids, it was possible to enumerate the important amino acids primarily responsible for protein stability present at the amino-terminal end of cystatin. Finally, pharmacophore elucidation carried out based on the information obtained from a series of small molecular inhibitors against meprin-α can be utilized in future for rational drug design and therapy.

20 September 2022 in Antonie van Leeuwenhoek
Verified
Journal Article
Closed access
PDF file
SAShaikh Rajesh Ali
Shaikh Rajesh Ali
SSSyeda Sagufta Sultana
Syeda Sagufta Sultana
SRSisir Rajak
Sisir Rajak
PTProsun Tribedi
Prosun Tribedi
SCSibani Sen Chakraborty
Sibani Sen Chakraborty

26 April 2019 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
ACAnkur Chaudhuri
Ankur Chaudhuri
NHNandagopal Hudait
Nandagopal Hudait
SCSibani Sen Chakraborty
Sibani Sen Chakraborty

1 February 2002 in Journal of Organometallic Chemistry
Verified
Journal Article
Closed access
SCSibani Chakraborty
Sibani Chakraborty
ABAsim K Bera
Asim K Bera
SBSuparna Bhattacharya
Suparna Bhattacharya
SGSreya Ghosh
Sreya Ghosh
APAsok K Pal
Asok K Pal
ABAsok Banerjee
Asok Banerjee

12 September 2017
Verified
Book Chapter
Closed access
PDF file
SCSibani Chakraborty
Sibani Chakraborty
ACAnkur Chaudhuri
Ankur Chaudhuri
ABAsim K. Bera
Asim K. Bera

11 June 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
YDYuthika Dholey
Yuthika Dholey
ACAnkur Chaudhuri
Ankur Chaudhuri
SCSibani Sen Chakraborty
Sibani Sen Chakraborty
Human meprin-β, a zinc metalloprotease belonging to the astacin family, have been found to be associated with many pathological conditions like inflammatory bowel disease, fibrosis and neurodegenerative disease. The inhibition of meprin-β by various inhibitors, both macromolecular and small molecules, is crucial in the control of several diseases. Human fetuin-A, a negative acute phase protein involved in inflammatory disease, has recently been identified as an endogenous inhibitor for meprin-β. In this computational study, an integrated in silico approach was performed using existing structural information of meprin-β coupled with ab initio modelling of human fetuin-A to predict a rational model of the complex through protein–protein docking. Further, the models were optimized and validated to generate an ensemble of conformations through extensive molecular dynamics simulation. Virtual alanine scanning mutagenesis was explored to identify hotspot residues on both proteins significant for protein–protein interaction (PPI). The results of the study provide structural insight into PPI between meprin-β and fetuin-A which can be useful in designing molecules to modulate meprin-β activity. Communicated by Ramaswamy H. Sarma